Table 1.
Target | Drug | # of Cancer Clinical Trials |
---|---|---|
CASP3 | 1541B | Pre-clinical |
PAC-1 | 3 | |
HDAC6 | Citarinostat | 5 |
Ricolinostat | 10 | |
MAPK14 (p38α) | Ralimetinib | 5 |
SCIO-469 | 3 | |
PAK4 | PF-03758309 | 1 |
PBK (TOPK) | OTS514 | Pre-clinical |
OTS964 | Pre-clinical | |
PIM1 | SGI-1776 | 2 |